Connor, Clark & Lunn Investment Management (CC&L)
MRVI icon

Connor, Clark & Lunn Investment Management (CC&L)’s Maravai LifeSciences MRVI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-316,502
Closed -$699K – 1617
2025
Q1 		$699K Sell
316,502
-131,492
-29% -$520K ﹤0.01% 1057
2024
Q4 		$2.44M Buy
447,994
+57,727
+15% +$371K 0.01% 669
2024
Q3 		$3.24M Sell
390,267
-60,195
-13% -$520K 0.02% 548
2024
Q2 		$3.23M Buy
450,462
+112,038
+33% +$967K 0.01% 536
2024
Q1 		$2.93M Buy
+338,424
New +$2.29M 0.01% 563

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.03B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.44B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return